Design and tuning of a cell-penetrating albumin derivative as a versatile nanovehicle for intracellular drug delivery

QR Code

Design and tuning of a cell-penetrating albumin derivative as a versatile nanovehicle for intracellular drug delivery

© 2018 Human serum albumin (HSA) is a superior carrier for delivering extracellular drugs. However, the development of a cell-penetrating HSA remains a great challenge due to its low membrane permeability. We report herein on the design of a series of palmitoyl-poly-arginine peptides (CPPs) and an e...

Full description

Bibliographic Details
Main Authors:	Ichimizu, S., Watanabe, H., Maeda, H., Hamasaki, K., Nakamura, Y., Chuang, Victor, Kinoshita, R., Nishida, K., Tanaka, R., Enoki, Y., Ishima, Y., Kuniyasu, A., Kobashigawa, Y., Morioka, H., Futaki, S., Otagiri, M., Maruyama, T.
Format:	Journal Article
Published:	Elsevier 2018
Online Access:	http://hdl.handle.net/20.500.11937/67803

Similar Items

Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer
by: Kinoshita, R., et al.
Published: (2017)

Potential use of human serum albumin as a drug delivery systems
by: Ishima, Y., et al.
Published: (2015)

Therapeutic impact of human serum albumin-thioredoxin fusion protein on influenza virus-induced lung injury mice
by: Tanaka, R., et al.
Published: (2014)

Albumin fusion prolongs the antioxidant and anti-inflammatory activities of thioredoxin in mice with acetaminophen-induced hepatitis
by: Tanaka, R., et al.
Published: (2014)

Apoptosis induction of poly-S-nitrosated human serum albumin in resistant solid tumor under hypoxia can be restored by phosphodiesterase 5 inhibition
by: Ikeda, M., et al.
Published: (2016)

S-Nitrosated human serum albumin dimer as novel nano-EPR enhancer applied to macromolecular anti-tumor drugs such as micelles and liposomes
by: Kinoshita, R., et al.
Published: (2015)

Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression
by: Tanaka, R., et al.
Published: (2013)

A novel S-sulfhydrated human serum albumin preparation suppresses melanin synthesis
by: Ikeda, M., et al.
Published: (2018)

Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nano-antioxidant for the treatment of two acute hepatitis models
by: Maeda, H., et al.
Published: (2015)

Albumin fusion of thioredoxin - The production and evaluation of its biological activity for potential therapeutic applications
by: Ikuta, S., et al.
Published: (2010)

A human serum albumin–thioredoxin fusion protein prevents experimental contrast-induced nephropathy
by: Kodama, A., et al.
Published: (2013)

Thioredoxin-albumin fusion protein prevents copper enhanced zinc-induced neurotoxicity via its antioxidative activity
by: Tanaka, K., et al.
Published: (2018)

Biological characteristics of two lysines on human serum albumin in the high affinity binding of m4Z,15Z-bilirubin-Ix[alpha] revealed by phage display
by: Minomo, A., et al.
Published: (2011)

Biological characteristics of two lysines on human serum albumin in the high affinity binding of m4Z,15Z-bilirubin-Ix[alpha] revealed by phage display
by: Minomo, A., et al.
Published: (2011)

Helix 6 of subdomain III A of human serum albumin is the region primarily photolabeled by ketoprofen, an arylpropionic acid NSAID containing a benzophenone moiety
by: Chuang, Victor, et al.
Published: (1999)

Redox properties of serum albumin
by: Anraku, M., et al.
Published: (2013)

Human serum albumin-thioredoxin fusion protein with long blood retention property is effective in suppressing lung injury
by: Furukawa, M., et al.
Published: (2011)

Albumin-drug interaction and its clinical implication
by: Yamasaki, K., et al.
Published: (2013)

Human serum albumin hydropersulfide is a potent reactive oxygen species scavenger in oxidative stress conditions such as chronic kidney disease
by: Shibata, A., et al.
Published: (2016)

Biological characteristics of two lysines on human serum albumin in the high-affinity binding of 4Z, 15Z-bilirubin-IXa revealed by phage display
by: Minomo, A., et al.
Published: (2011)

Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions
by: Minayoshi, Y., et al.
Published: (2018)

Subdomain IIIA of Dog Albumin Contains a Binding Site Similar to Site II of Human Albumin
by: Kaneko, K., et al.
Published: (2008)

Recombinant human serum albumin
by: Chuang, Victor, et al.
Published: (2007)

Differential Effects of Methoxy Group on the Interaction of Curcuminoids with Two Major Ligand Binding Sites of Human Serum Albumin
by: Sato, H., et al.
Published: (2014)

Albumin domain II mutant with high bilirubin binding affinity has a great potential as serum bilirubin excretion enhancer for hyperbilirubinemia treatment
by: Minomo, Ai, et al.
Published: (2013)

Albumin fusion renders thioredoxin an effective anti-oxidative and anti-inflammatory agent for preventing cisplatin-induced nephrotoxicity
by: Kodama, A., et al.
Published: (2014)

Quantitative determination of polysulfide in albumins, plasma proteins and biological fluid samples using a novel combined assays approach
by: Ikeda, M., et al.
Published: (2017)

Stereoselective Binding of Human Serum Albumin
by: Chuang, Victor, et al.
Published: (2006)

Pharmaceutical Aspects of the Recombinant Human Serum Albumin Dimer: Structural Characteristics, Biological Properties, and Medical Applications
by: Taguchi, K., et al.
Published: (2012)

Pharmaceutically Important Pre- and Posttranslational Modifications on Human Serum Albumin
by: Otagiri, M., et al.
Published: (2009)

Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases
by: Nagumo, K., et al.
Published: (2014)

Arginine 485 of human serum albumin interacts with the benzophenone moiety of ketoprofen in the binding pocket of subdomain III A and III B
by: Kaneko, K., et al.
Published: (2012)

Pleiotropic effects of levofloxacin, fluoroquinolone antibiotics, against influenza virus-induced lung injury
by: Enoki, Y., et al.
Published: (2015)

How Do Fatty Acids Cause Allosteric Binding of Drugs to Human Serum Albumin?
by: Chuang, Victor, et al.
Published: (2002)

Carbon materials as new nanovehicles in hot-melt drug deposition
by: Bielicka, Agnieszka, et al.
Published: (2013)

Cross-linked human serum albumin dimer has the potential for use as a plasma-retaining agent for the fatty acid-conjugated antidiabetic drugs
by: Taguchi, K., et al.
Published: (2015)

A uremic toxin 3-carboxy-4-methyl-5-propyl-2-furanpropionate accumulates in proximal tubular cells and induces cell damage through increasing oxidative stress
by: Miyamoto, Y., et al.
Published: (2012)

The potential of a cross-linked human serum albumin dimer in diabetic rats as an augmenting agent for antidiabetic drugs
by: Taguchi, K., et al.
Published: (2015)

Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin
by: Kragh-Hansen, U., et al.
Published: (2002)

Flunitrazepam, a 7-nitro-1,4-benzodiazepine that is unable to bind to the indole-benzodiazepine site of human serum albumin
by: Chuang, Victor, et al.
Published: (2001)

Cannot write session to /tmp/vufind_sessions/sess_ga4ipl8i5sulq3qv5tu9orb0ad